← 返回

组织驻留 FOLR2(+) 巨噬细胞与人类乳腺癌中 CD8(+) T 细胞浸润相关

英文原题:Tissue-resident FOLR2(+) macrophages associate with CD8(+) T cell infiltration in human breast cancer.

查看英文原题

Tissue-resident FOLR2(+) macrophages associate with CD8(+) T cell infiltration in human breast cancer.

PubMed 2022/03/23(内容时间) Cell Q1 · IF 45.1(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

中文摘要

巨噬细胞浸润是实体癌的一个标志,总体巨噬细胞浸润与患者较低的生存率和治疗耐药性相关。然而,肿瘤相关巨噬细胞在表型和功能上具有异质性。特定的肿瘤相关巨噬细胞亚群可能在癌症进展和抗肿瘤免疫中具有不同的作用。在此,我们在健康乳腺和乳腺癌原发肿瘤中鉴定出一个离散的 FOLR2 + 组织驻留巨噬细胞群体。FOLR2 + 巨噬细胞定位于肿瘤间质的血管周围区域,在那里它们与 CD8 + T 细胞相互作用。FOLR2 + 巨噬细胞在体外能有效致敏效应 CD8 + T 细胞。肿瘤中 FOLR2 + 巨噬细胞的密度与患者更好的生存率呈正相关。本研究强调了肿瘤相关巨噬细胞亚群的特定作用,并为基于巨噬细胞的癌症治疗中亚群靶向治疗干预铺平了道路。

展开英文摘要原文

Macrophage infiltration is a hallmark of solid cancers, and overall macrophage infiltration correlates with lower patient survival and resistance to therapy. Tumor-associated macrophages, however, are phenotypically and functionally heterogeneous. Specific subsets of tumor-associated macrophage might be endowed with distinct roles on cancer progression and antitumor immunity.

Here, we identify a discrete population of FOLR2 + tissue-resident macrophages in healthy mammary gland and breast cancer primary tumors. FOLR2 + macrophages localize in perivascular areas in the tumor stroma, where they interact with CD8 + T cells. FOLR2 + macrophages efficiently prime effector CD8 + T cells ex vivo. The density of FOLR2 + macrophages in tumors positively correlates with better patient survival.

This study highlights specific roles for tumor-associated macrophage subsets and paves the way for subset-targeted therapeutic interventions in macrophages-based cancer therapies.

论文信息

作者
Nalio Ramos R、Missolo-Koussou Y、Gerber-Ferder Y、Bromley CP、Bugatti M、Núñez NG、Tosello Boari J、Richer W
第一作者单位
PSL University, Institut Curie Research Center, INSERM U932 & SiRIC, Translational Immunotherapy Team, 75005 Paris, France.France
通讯作者单位
PSL University, Institut Curie Research Center, INSERM U932 & SiRIC, Translational Immunotherapy Team, 75005 Paris, France. Electronic address: julie.helft@inserm.fr.France
文献类型
非美国政府资助研究
期刊
Cell2022 Mar 31
原文标识
PubMed 35325594 · DOI 10.1016/j.cell.2022.02.021